Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | PO / MO |
The patient took only the first two doses of Vivotif and then failed to take the last two doses; it has been two weeks since the patient took the first two doses.; Case reference number US-BN-2025-001175 is a spontaneous case initially received from a pharmacist via Communication (reference number: USBAV25-1659) on 09-Jul-2025 and concerns a child patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took the first two doses of Vivotif (batch number: 3004299) orally, at an unknown dose, for an unknown indication. The patient failed to take the last two doses, it has been two weeks since the patient took the first two doses (explicitly coded as 'incomplete course of vaccination'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. No further information was provided.; Reporter's Comments: A child patient of unspecified age took the first two doses of Vivotif for an unknown indication. The patient failed to take the last two doses, it has been two weeks since the patient took the first two doses, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A child patient of unspecified age took the first two doses of Vivotif for an unknown indication. The patient failed to take the last two doses, it has been two weeks since the patient took the first two doses, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE